Clinical Trials · NCT00521300

Preoperative Octreotide Treatment of Acromegaly

CompletedPhase 4Octreotide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
St. Olavs Hospital
Enrollment
62
Start date
Sep 1999
Locations
5 sites, Norway
Primary endpoint
Surgical cure by transsphenoidal surgery
View Octreotide compound reference